Loading clinical trials...

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT07184814

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).

Lead sponsor: China-Japan Friendship Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Wanmu Xie, Doctor

CONTACT

15611734410 [email protected]

Related studies

RECRUITING

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

NCT05388682 · Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 22, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment150

Start dateJan 2016

Last updatedSep 22, 2025

Condition

Takayasu Arteritis With Pulmonary Artery Involvement

Locations shown

China-Japan Friendship hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 22, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions